Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) MeetingGlobeNewsWire • 08/07/23
Evoke Pharma and EVERSANA Announce Abstract Selection for Plenary Oral Presentation at The American College of Gastroenterology (ACG) 2023 Annual MeetingGlobeNewsWire • 07/25/23
Evoke Pharma to Host First Key Opinion Leader Webinar on Healthcare Resource Utilization Data Related to Gastroparesis and its TreatmentGlobeNewsWire • 06/14/23
Real-World Data Presented by Evoke Pharma and EVERSANA at Digestive Disease Week 2023 Shows Gimoti® Meaningfully Reduces Utilization of Healthcare ResourcesGlobeNewsWire • 05/09/23
Evoke Pharma's Real-World Healthcare Utilization Data Comparing GIMOTI® to Oral Metoclopramide to Be Presented at Digestive Disease Week (DDW) 2023GlobeNewsWire • 05/04/23
United States Patent and Trademark Office (USPTO) Grants Evoke Pharma a Formulation Patent Covering GIMOTIGlobeNewsWire • 04/20/23
Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related PatentGlobeNewsWire • 04/06/23
Evoke Pharma & EVERSANA Announce Compelling Real-World Data on the Impact of GIMOTI in Reducing the Utilization of Healthcare Resources to be Presented at the Academy of Managed Care Pharmacy (AMCP) 2023GlobeNewsWire • 03/23/23
Evoke Pharma to Report Fourth Quarter and Full Year 2022 Results on March 21, 2023GlobeNewsWire • 03/15/23
Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Study Comparing GIMOTI® and Oral Metoclopramide at the Digestive Disease Week Plenary SessionGlobeNewsWire • 02/21/23
Evoke Pharma Announces Acceptance of an Abstract at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2023GlobeNewsWire • 01/18/23
USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI® To Treat Moderate to Severe GastroparesisGlobeNewsWire • 12/07/22
Evoke Pharma Strengthens its Intellectual Property Portfolio with a Notice of Allowance from the USPTO for a Patent Application Related to GIMOTI®GlobeNewsWire • 11/30/22
Evoke Pharma to Participate in the 2022 American College of Gastroenterology Annual Scientific MeetingGlobeNewsWire • 10/20/22
Evoke Pharma Receives Notice of Allowance from USPTO for a Patent Related to GIMOTIGlobeNewsWire • 09/20/22